ScopusElsevier Scopus
Status
Active
Coverage
1996–2026; 1960-1961
Source type
Journal
Open access
No
CiteScore
3.4
Best quartile
Q3 · 45th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 153 / 278 | 45th | Q3 |
| Pharmacology | 200 / 328 | 39th | Q3 |
American Journal of Therapeutics
ISSN 1075-2765 · 1536-3686
Publisher: Lippincott Williams and Wilkins
Scopus · Q3WoS · SCIEONOS
Is American Journal of Therapeutics indexed in Scopus? Yes — actively indexed in Scopus, coverage 1996–2026; 1960-1961, best quartile Q3, CiteScore 3.4.
Is American Journal of Therapeutics in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is American Journal of Therapeutics open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
3.4
CiteScore 2025
Scopus
Q3
Best quartile
45th percentile
2
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.